These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

295 related articles for article (PubMed ID: 35653983)

  • 1. Characteristics of patients with brain metastases from human epidermal growth factor receptor 2-positive breast cancer: subanalysis of Brain Metastases in Breast Cancer Registry.
    Laakmann E; Witzel I; Neunhöffer T; Park-Simon TW; Weide R; Riecke K; Polasik A; Schmidt M; Puppe J; Mundhenke C; Lübbe K; Hesse T; Thill M; Zahm DM; Denkert C; Fehm T; Nekljudova V; Rey J; Loibl S; Müller V
    ESMO Open; 2022 Jun; 7(3):100495. PubMed ID: 35653983
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Treatment and outcomes of patients in the Brain Metastases in Breast Cancer Network Registry.
    Witzel I; Laakmann E; Weide R; Neunhöffer T; Park-Simon TJ; Schmidt M; Fasching PA; Hesse T; Polasik A; Mohrmann S; Würschmidt F; Schem C; Bechtner C; Würstlein R; Fehm T; Möbus V; Burchardi N; Loibl S; Müller V
    Eur J Cancer; 2018 Oct; 102():1-9. PubMed ID: 30099223
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Long-term survival of breast cancer patients with brain metastases: subanalysis of the BMBC registry.
    Riecke K; Müller V; Neunhöffer T; Park-Simon TW; Weide R; Polasik A; Schmidt M; Puppe J; Mundhenke C; Lübbe K; Hesse T; Thill M; Wuerstlein R; Denkert C; Decker T; Fehm T; Nekljudova V; Rey J; Loibl S; Laakmann E; Witzel I
    ESMO Open; 2023 Jun; 8(3):101213. PubMed ID: 37075697
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Radiological Patterns of Brain Metastases in Breast Cancer Patients: A Subproject of the German Brain Metastases in Breast Cancer (BMBC) Registry.
    Laakmann E; Witzel I; Scriba V; Grzyska U; Zu Eulenburg C; Burchardi N; Hesse T; Würschmidt F; Fehm T; Möbus V; von Minckwitz G; Loibl S; Park-Simon TW; Mueller V
    Int J Mol Sci; 2016 Sep; 17(10):. PubMed ID: 27669228
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Survival analysis of patients with brain metastases at initial breast cancer diagnosis over the last decade.
    Avila J; Leone J; Vallejo CT; Lin NU; Leone JP
    Breast Cancer Res Treat; 2024 Jun; 205(3):579-587. PubMed ID: 38453783
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prognostic value of human epidermal growth factor receptor 2 status and systemic therapy in breast cancer with brain metastases treated with radiotherapy.
    Tsuruoka S; Kataoka M; Uwatsu K; Makita K; Tsuruoka K; Takata N; Ishikawa H; Hamamoto Y; Mochizuki T; Kido T
    Asia Pac J Clin Oncol; 2023 Jun; 19(3):347-354. PubMed ID: 36281655
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Stereotactic Radiosurgery for Women Older than 65 with Breast Cancer Brain Metastases.
    Upadhyay R; Klamer BG; Perlow HK; White JR; Bazan JG; Jhawar SR; Blakaj DM; Grecula JC; Arnett A; Mestres-Villanueva MA; Healy EH; Thomas EM; Chakravarti A; Raval RR; Lustberg M; Williams NO; Palmer JD; Beyer SJ
    Cancers (Basel); 2023 Dec; 16(1):. PubMed ID: 38201564
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hormone receptors status: a strong determinant of the kinetics of brain metastases occurrence compared with HER2 status in breast cancer.
    Darlix A; Griguolo G; Thezenas S; Kantelhardt E; Thomssen C; Dieci MV; Miglietta F; Conte P; Braccini AL; Ferrero JM; Bailleux C; Jacot W; Guarneri V
    J Neurooncol; 2018 Jun; 138(2):369-382. PubMed ID: 29488184
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prognostic factors and survival according to tumour subtype in women presenting with breast cancer brain metastases at initial diagnosis.
    Leone JP; Leone J; Zwenger AO; Iturbe J; Leone BA; Vallejo CT
    Eur J Cancer; 2017 Mar; 74():17-25. PubMed ID: 28335884
    [TBL] [Abstract][Full Text] [Related]  

  • 10. New brain metastases after whole-brain radiotherapy of initial brain metastases in breast cancer patients: the significance of molecular subtypes (KROG 16-12).
    Kim JS; Kim K; Jung W; Shin KH; Im SA; Kim HJ; Kim YB; Chang JS; Kim JH; Choi DH; Park YH; Kim DY; Kim TH; Choi BO; Lee SW; Kim S; Kwon J; Kang KM; Chung WK; Kim KS; Yoon WS; Kim JH; Cha J; Oh YK; Kim IA
    Breast Cancer Res Treat; 2021 Apr; 186(2):453-462. PubMed ID: 33392845
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prognostic Value of Intrinsic Subtypes in Hormone Receptor-Positive Metastatic Breast Cancer Treated With Letrozole With or Without Lapatinib.
    Prat A; Cheang MC; Galván P; Nuciforo P; Paré L; Adamo B; Muñoz M; Viladot M; Press MF; Gagnon R; Ellis C; Johnston S
    JAMA Oncol; 2016 Oct; 2(10):1287-1294. PubMed ID: 27281556
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The prognostic contribution of clinical breast cancer subtype, age, and race among patients with breast cancer brain metastases.
    Anders CK; Deal AM; Miller CR; Khorram C; Meng H; Burrows E; Livasy C; Fritchie K; Ewend MG; Perou CM; Carey LA
    Cancer; 2011 Apr; 117(8):1602-11. PubMed ID: 21472708
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Brain metastases in breast cancer: clinical and pathologic characteristics associated with improvements in survival.
    Melisko ME; Moore DH; Sneed PK; De Franco J; Rugo HS
    J Neurooncol; 2008 Jul; 88(3):359-65. PubMed ID: 18398574
    [TBL] [Abstract][Full Text] [Related]  

  • 14. HER2 Receptor Conversion Is a strong Survival Predictor in Patients with Breast Cancer Brain Metastases.
    Michel A; Oppong MD; Rauschenbach L; Pierscianek D; Dinger TF; Schmidt T; Hense J; Pöttgen C; Kimmig R; Ahmadipour Y; Özkan N; Müller O; Junker A; Sure U; Jabbarli R; El Hindy N
    World Neurosurg; 2021 Aug; 152():e332-e343. PubMed ID: 34062302
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Risk and prognostic factors of breast cancer with liver metastases.
    Ji L; Cheng L; Zhu X; Gao Y; Fan L; Wang Z
    BMC Cancer; 2021 Mar; 21(1):238. PubMed ID: 33676449
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Incidence and outcome of brain and/or leptomeningeal metastases in HER2-low metastatic breast cancer in the French ESME cohort.
    Epaillard N; Lusque A; Jacot W; Mailliez A; Bachelot T; Arnedos M; Le Du F; Brain E; Ferrero JM; Massard V; Desmoulins I; Mouret-Reynier MA; Levy C; Gonçalves A; Leheurteur M; Petit T; Filleron T; Bosquet L; Pistilli B; Frenel JS
    ESMO Open; 2024 May; 9(5):103447. PubMed ID: 38703431
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prognostic Factors and Survival According to Tumor Subtype in Women With Breast Cancer Brain Metastases.
    Lopes S; Vieira I; Abreu M; Pousa I; Ferreira A; Sousa S; Pereira D
    Curr Probl Cancer; 2022 Dec; 46(6):100866. PubMed ID: 36179388
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinicopathological and Treatment-Associated Prognostic Factors in Patients with Breast Cancer Leptomeningeal Metastases in Relation to Tumor Biology.
    Griguolo G; Pouderoux S; Dieci MV; Jacot W; Bourgier C; Miglietta F; Firmin N; Conte P; Viala M; Guarneri V; Darlix A
    Oncologist; 2018 Nov; 23(11):1289-1299. PubMed ID: 30120164
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A systematic review of trastuzumab and lapatinib in the treatment of women with brain metastases from HER2-positive breast cancer.
    Larsen PB; Kümler I; Nielsen DL
    Cancer Treat Rev; 2013 Nov; 39(7):720-7. PubMed ID: 23481218
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Breast cancer subtypes and survival in patients with brain metastases.
    Nam BH; Kim SY; Han HS; Kwon Y; Lee KS; Kim TH; Ro J
    Breast Cancer Res; 2008; 10(1):R20. PubMed ID: 18307763
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.